ARTICLE | Finance
RaQualia scores
RaQualia one of the biggest ever biotech IPOs in Japan
July 18, 2011 7:00 AM UTC
In one of the largest biotech IPOs ever in Japan, RaQualia Pharma Inc. last week raised ¥6.4 billion ($79.4 million), giving it a post-money valuation of ¥21.5 billion ($266.6 million) and putting its deal among the top tier of biopharma IPOs for the year.
The company sold 4 million shares at ¥1,600 and will begin trading July 20 on the JASDAQ Growth Market of the Osaka Securities Exchange. Underwriters included Daiwa Securities and 12 other firms...